Cite
MLA Citation
Roela Sadushi-Kolici et al.. “Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial.” Lancet, vol. 7, no. 3, 2019, pp. 239–248. http://access.bl.uk/ark:/81055/vdc_100077975413.0x000005